Readoutin 75d
ModernaTX, Inc. — mRNA-1403
Phase 3 primary completion: A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis.
- Date
- Feb 2027
- Type
- Readout
- Indication
- Acute Gastroenteritis